| Wanbury Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524212 |
NSE Symbol : WANBURY |
P/E(TTM) : 13.36 |
|
ISIN Demat : INE107F01022 |
Div & Yield% : 0.00 |
EPS(TTM) : 19.95 |
|
Book Value(₹) : 41.34 |
Market Cap(₹Cr) : 931.48 |
Face Value(₹) : 10.00 |
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 164.58 | 162.45 | 160.06 | 163.18 | 172.00 | 133.45 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 164.58 | 162.45 | 160.06 | 163.18 | 172.00 | 133.45 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.21 | 0.18 | 0.20 | 0.35 | 1.84 | 0.84 |
| Total Income | 164.79 | 162.63 | 160.26 | 163.53 | 173.84 | 134.29 |
| Total Expenditure | 138.34 | 135.76 | 134.28 | 138.74 | 142.37 | 119.51 |
| PBIDT | 26.45 | 26.86 | 25.98 | 24.79 | 31.47 | 14.78 |
| Interest | 8.06 | 7.26 | 7.12 | 7.54 | 9.04 | 10.17 |
| PBDT | 18.39 | 19.60 | 18.86 | 17.25 | 22.43 | 4.62 |
| Depreciation | 3.23 | 3.74 | 3.70 | 3.64 | 3.37 | 3.32 |
| Tax | 0.65 | 0.00 | 0.00 | 0.00 | 5.86 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -7.19 | 0.11 | -0.02 | 0.12 | -7.06 | 0.07 |
| Reported Profit After Tax | 21.70 | 15.76 | 15.18 | 13.49 | 20.26 | 1.22 |
| Extra-ordinary Items | -3.45 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 25.15 | 15.76 | 15.18 | 13.49 | 20.26 | 1.22 |
| EPS (Unit Curr.) | 7.26 | 4.52 | 4.58 | 4.12 | 6.18 | 0.38 |
| EPS (Adj) (Unit Curr.) | 7.26 | 4.52 | 4.58 | 4.12 | 6.18 | 0.38 |
| Calculated EPS (Unit Curr.) | 6.21 | 4.52 | 4.35 | 4.10 | 6.18 | 0.37 |
| Calculated EPS (Adj) (Unit Curr.) | 6.21 | 4.52 | 4.35 | 4.10 | 6.18 | 0.37 |
| Calculated EPS (Ann.) (Unit Curr.) | 24.85 | 18.07 | 17.41 | 16.41 | 24.73 | 1.49 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 24.85 | 18.07 | 17.41 | 16.41 | 24.73 | 1.49 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 34.94 | 34.89 | 34.88 | 32.88 | 32.77 | 32.77 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 16.07 | 16.53 | 16.23 | 15.19 | 18.30 | 11.08 |
| PBDTM(%) | 11.17 | 12.07 | 11.78 | 10.57 | 13.04 | 3.46 |
| PATM(%) | 13.19 | 9.70 | 9.48 | 8.27 | 11.78 | 0.91 |
